8a7883d08c3cac02018c5a349bd52a35
The National Strategic Research Institute at the University of Nebraska is seeking a Director, Prophylactics & Therapeutics to lead research projects and oversee the Medical Countermeasures Therapeutics Program. This role focuses on developing therapeutics and pre-exposure prophylactics to counter CBRNE threat sequelae for the Department of War and other federal customers. The position involves managing research efforts, securing funding, and coordinating with internal and external stakeholders to meet strategic objectives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 8a7883d08c3cac02018c5a349bd52a35.
Open Rank
University of North Carolina at Chapel Hill
Academic Rank/Depends on Qualifications
PeopleAdmin
Scientist II, Chem & Mol Therapeutics
biogen
Therapeutics Programmatic and Technical Advisor
Booz Allen Hamilton
Head, Oncology Immune Therapeutics
Novartis
Vaccines & Prophylactics Programmatic & Technical Advisor
Booz Allen Hamilton